Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David C. C. Tsui"'
Autor:
Terry L. Ng, David C. C. Tsui, Sherry Wang, Tiziana Usari, Tejas Patil, Keith Wilner, David R. Camidge
Publikováno v:
Cancer Medicine, Vol 11, Iss 23, Pp 4422-4429 (2022)
Abstract Background ROS1‐ and ALK‐rearranged advanced NSCLCs are associated with increased thromboembolic risk. We hypothesized that a prothrombotic phenotype offers an evolutionary advantage to subsets of these cancers. The impact of this phenot
Externí odkaz:
https://doaj.org/article/d232c69eaa9f4736a6702737e390c6d8
Autor:
David C C, Tsui, Leylah M, Drusbosky, Sara, Wienke, Dexiang, Gao, Adrian, Bubie, Catalin, Barbacioru, D Ross, Camidge
Publikováno v:
Clinical Lung Cancer. 23:630-638
Defining clinically relevant MET amplification levels in non-small cell lung cancer (NSCLC) remains challenging. We hypothesize that oncogene overlap and MET amplicon size decline with increase in MET plasma copy number (pCN), thus enriching for MET-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df3d93e0015422dd770777a8f5b637fd
https://doi.org/10.1016/j.cllc.2022.07.002
https://doi.org/10.1016/j.cllc.2022.07.002
Autor:
Ng, Terry L.1 (AUTHOR) teng@toh.ca, Tsui, David C. C.2 (AUTHOR), Wang, Sherry3 (AUTHOR), Usari, Tiziana4 (AUTHOR), Patil, Tejas2 (AUTHOR), Wilner, Keith5 (AUTHOR), Camidge, David R.2 (AUTHOR)
Publikováno v:
Cancer Medicine. Dec2022, Vol. 11 Issue 23, p4422-4429. 8p.
Publikováno v:
Cancer Weekly; 3/21/2023, p1197-1197, 1p